首页> 外国专利> INTRAOCULAR PATHOLOGIC NEOVASCULARIZATION INHIBITOR, MEDICINE FOR PREVENTING AND/OR TREATING INTRAOCULAR NEOVASCULARIZATION DISEASE, AND METHOD FOR SCREENING THE SAME

INTRAOCULAR PATHOLOGIC NEOVASCULARIZATION INHIBITOR, MEDICINE FOR PREVENTING AND/OR TREATING INTRAOCULAR NEOVASCULARIZATION DISEASE, AND METHOD FOR SCREENING THE SAME

机译:眼内病理性神经凝集抑制剂,预防和/或治疗眼内神经凝集性疾病的药物及其筛查方法

摘要

PROBLEM TO BE SOLVED: To provide an intraocular pathologic neovascularization inhibitor having an action for effectively inhibiting intraocular neovascularization, to provide a medicine for preventing and/or treating an intraocular neovascularization disease, and to provide a method for efficiently screening the preventing/treating medicine with an Lnk-deficient retinal ischemia model.;SOLUTION: This intraocular pathologic neovascularization inhibitor contains, as an active ingredient, a substance which inhibits the expression or function of an Lnk gene. The intraocular neovascularization disease includes ischemic proliferative retinopathy, macular edema, age-related macular degeneration, neovascular glaucoma, corneal neovascularization, and choroidal neovascularization. The method for efficiently screening the medicine for preventing/treating the intraocular neovascularization disease comprises administering a test substance in retinal ischemia model non-human animal and then evaluating the extent of the regeneration at the retinal ischemia site of the non-human animal.;COPYRIGHT: (C)2007,JPO&INPIT
机译:解决的问题:提供一种具有有效抑制眼内新血管形成作用的眼内病理性新血管形成抑制剂,提供一种预防和/或治疗眼内新血管形成疾病的药物,并提供一种有效地筛查预防/治疗药物的方法。解决方案:这种眼内病理性新血管形成抑制剂含有抑制Lnk基因表达或功能的物质作为有效成分。眼内新血管形成疾病包括缺血性增生性视网膜病,黄斑水肿,与年龄有关的黄斑变性,新血管青光眼,角膜新血管形成和脉络膜新血管形成。有效地筛选用于预防/治疗眼内新血管形成疾病的药物的方法包括在视网膜缺血模型非人类动物中施用测试物质,然后评估该非人类动物的视网膜缺血部位的再生程度。 :(C)2007,JPO&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号